-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|December 22, 2023

Payor Considerations In MDS Management

The panelists highlight key takeaways for payors involved in MDS treatment.

Episodes in this series

EP. 1 Myelodysplastic Syndrome (MDS) Overview

EP. 1 Myelodysplastic Syndrome (MDS) Overview

EP. 2 Distinguishing Between Different MDS Subtypes

EP. 2 Distinguishing Between Different MDS Subtypes

EP. 3 MDS-Related Complications Impacting Patient Quality of Life

EP. 3 MDS-Related Complications Impacting Patient Quality of Life

EP. 4 Economic Implications of MDS Management

EP. 4 Economic Implications of MDS Management

EP. 5 Examining Treatment Algorithms for MDS

EP. 5 Examining Treatment Algorithms for MDS

EP. 6 Growth Factor and Stem Cell Transplant Candidacy in MDS

EP. 6 Growth Factor and Stem Cell Transplant Candidacy in MDS

EP. 7 Novel Agents Contributing to Evolving MDS Therapy Strategies

EP. 7 Novel Agents Contributing to Evolving MDS Therapy Strategies

EP. 8 Benefits of Oral Therapies In MDS Treatment Adherence

EP. 8 Benefits of Oral Therapies In MDS Treatment Adherence

EP. 9 Adapting MDS Treatment Approach

EP. 9 Adapting MDS Treatment Approach

EP. 10 Novel Therapy Impact on Patient Quality of Life

EP. 10 Novel Therapy Impact on Patient Quality of Life

Video 11 - "Multidisciplinary Care Driving Effective MDS Treatment"

EP. 11 Multidisciplinary Care Driving Effective MDS Treatment

Video 12 - "Payor Considerations In MDS Management"

EP. 12 Payor Considerations In MDS Management

Video 12 - "Payor Considerations In MDS Management"

EP. 13 Navigating Insurance-Related Challenges Associated With MDS Treatment

Video 12 - "Payor Considerations In MDS Management"

EP. 14 Key Considerations Surrounding MDS Treatment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Ying Huang, PhD | Image: Legend Biotech

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

ByProduced by Mary Caffrey

June 22nd 2026

Catching DME Patients Before They Fall Off the Radar: Sunir Garg, MD

ByLaura Joszt, MA,Sunir Garg, MD

June 22nd 2026

Navigating the Human Side of Extrapulmonary Neuroendocrine Carcinoma: Patient Burden and Caregiver Support

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

The 5-Year Horizon: Evolving Paradigms in Ischemic Stroke Management

ByMark Makhinson, PharmD, MBA,Andrew Russman, DO, FAHA, FAAN,Danison Emmerson, MD,David Z. Rose, MD

June 22nd 2026

Closing the Gap: Underrecognition and the Critical Need for Early Diagnosis in Extrapulmonary Neuroendocrine Carcinoma

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

Trending on AJMC

Health Care Is Fixable: Workers’ Compensation Shows Employers Don’t Need to Wait for Washington

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM

FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies